| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,902 |
3,350 |
$264K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,780 |
2,451 |
$213K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,109 |
2,296 |
$72K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
733 |
640 |
$49K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
637 |
564 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
738 |
569 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
684 |
498 |
$10K |
| S9083 |
Global fee urgent care centers |
135 |
105 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,391 |
427 |
$6K |
| 99215 |
Prolong outpt/office vis |
68 |
56 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
512 |
368 |
$4K |
| 99205 |
Prolong outpt/office vis |
19 |
17 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
247 |
189 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
17 |
$1K |
| 0012A |
|
22 |
19 |
$361.24 |
| 0011A |
|
17 |
16 |
$88.92 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
48 |
33 |
$50.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
49 |
33 |
$15.40 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
124 |
83 |
$0.00 |